Hep C Antibody Prevalence
Data Relibility is set to low, fair or good according to a scoring system of 0 to 100 on comparability, contemporariness, and consistency.
Data with a low reliability is often an estimate based on prevalence in a similar state or a national mean. It may also represent data that were collected from national survey by journalism fellow, without clarification of antibody or viremia.
Data with a fair reliability may be data that are consistent and contemporary, but it is unclear how testing for HCV is done in the state, or how prevalence was calculated. Or, it may be good data that are not contemporary or consistent with estimates given to the press.
Data with a good reliability may be based on non-targeted screening or a non-targeted study, and appropriate methods of calculating prevalence. It is also either contemporary and/or consistent.
For more details on the data reliability scoring system, please visit our Methods section.
Select a State:
Click a State to view detailed information.
Hep C Viremia Prevalence
Select a State:
Click a State to view detailed information.
Hep C Treatment
Select a State:
Click a State to view detailed information.
Filter data by reliability: |
×
Data Relibility is set to low, fair or good according to following criteria: low reliabilityData taken by extrapolation from similar state; at worse, assumed to be at national mean OR prevalence data from national survey by journalism fellow, without clarification of antibody or viremia. fair reliabilityMay be somewhat targeted OR only limited portion of population; in prison where medical staff attest to systematic surveillance at least once. May be judged less than “good” if number given t o journalism fellow differs substantially from number provided on survey of medical directors. good reliabilityNon-targeted cross section of entire population, with confirmation that data is antibody specific, and methods used seem appropriate. (In most instances confirmed by discussion with on-site providers of the data.) |